Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sandwich therapy in testis tumor: current experience.

D F Lynch, L P McCord, T C Nicholson

    The Journal of Urology
    |May 1, 1978
    PubMed
    Summary

    Sandwich therapy for non-seminomatous testis tumors showed an 84% survival rate. However, due to severe side effects and better outcomes with other treatments, this approach is no longer standard.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dietary Methionine and Total Sulfur Amino Acid Restriction in Healthy Adults.

    The journal of nutrition, health & aging·2023
    Same author

    Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function.

    European journal of clinical nutrition·2017
    Same author

    Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women.

    European journal of clinical nutrition·2017
    Same author

    Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial.

    European journal of clinical nutrition·2012
    Same author

    Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer.

    The Journal of urology·2011
    Same author

    Tumor, nodes, metastasis (TNM) classification of bladder cancer.

    Urologic oncology·2011

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Radiation Oncology

    Background:

    • Non-seminomatous testis tumors require effective treatment regimens.
    • Sandwich therapy, combining surgery and radiation, was previously used.
    • Assessing long-term outcomes and side effects is crucial for treatment optimization.

    Purpose of the Study:

    • To evaluate the efficacy and safety of sandwich therapy for non-seminomatous testis tumors.
    • To compare sandwich therapy outcomes with alternative treatment modalities.
    • To inform clinical practice regarding the standard of care for these tumors.

    Main Methods:

    • Retrospective analysis of 13 patients with stages A and B non-seminomatous testis tumors treated with sandwich therapy.
    • Review of historical data from 35 patients treated with the same regimen between 1958 and 1970.
    • Documentation of survival rates and treatment-related side effects.

    Main Results:

    • Sandwich therapy achieved an 84% survival rate in the current cohort, consistent with a previous 83% rate.
    • Significant side effects included bone marrow depression, retroperitoneal fibrosis, and potential secondary malignancies.
    • Alternative treatments (lymphadenectomy alone or with chemotherapy) demonstrated superior survival with fewer adverse events.

    Conclusions:

    • While sandwich therapy demonstrated a notable survival rate, its associated severe side effects are a concern.
    • The advent of more effective and less toxic treatments necessitates a shift away from sandwich therapy.
    • Discontinuation of sandwich therapy as a standard treatment for non-seminomatous testis tumors is recommended at this institution.

    Related Experiment Videos